Patients recently diagnosed with COVID-19 now have a treatment option that may help speed up their recovery process and lower their chances of being admitted to the hospital.
Monoclonal Antibody Therapy is an investigational treatment approved by the U.S. Food and Drug Administration to treat COVID-19 pediatric and adult patients experiencing mild to moderate symptoms.
In this video, Augusta University Health‘s Chief Medical Officer Dr. Phillip Coule shares what you need to know about Monoclonal Antibody Therapy and more important facts about the coronavirus.
Visit AU Health’s Virtual Care to find out if you qualify for this treatment, and keep up with the latest COVID-19 news and statisticsĀ here.